Immuneering Corp Financial Flexibility Index
Immuneering Corp financial flexibility index. Immuneering Corp (IMRX) has a Financial Flexibility Index of -0.92x as of September 2025. Free cash flow of $-11.97 Million (operating CF $-11.98 Million minus capex $7.25K) represents -1% of total liabilities ($13.08 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Immuneering Corp (2019–2024)
Financial flexibility index of Immuneering Corp from 2019 to 2024. Historical Financial Flexibility Index trend for Immuneering Corp across 6 annual periods. Explore how well can Immuneering Corp service its debt to assess how comfortably operating cash covers total debt obligations.
Immuneering Corp Financial Flexibility Index by Year (2019–2024)
Immuneering Corp financial flexibility index by year from 2019 to 2024. Year-by-year free cash flow to debt coverage for Immuneering Corp. For the full cash flow conversion analysis, see IMRX cash generation efficiency.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -4.85x | $-54.91 Million | $-55.00 Million | $11.33 Million | ▼ -19.7% |
| 2023 | -4.05x | $-48.63 Million | $-48.97 Million | $12.01 Million | ▼ -16.9% |
| 2022 | -3.46x | $-43.36 Million | $-44.10 Million | $12.52 Million | ▼ -20.7% |
| 2021 | -2.87x | $-30.79 Million | $-30.85 Million | $10.72 Million | ▼ -1100.3% |
| 2020 | -0.24x | $-14.57 Million | $-14.62 Million | $60.90 Million | ▼ -11.6% |
| 2019 | -0.21x | $-4.42 Million | $-4.44 Million | $20.63 Million | — |